http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019120112-A9
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bfe54347d8425000507f2bddaaf7701b |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2730-10134 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-29 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127 |
filingDate | 2018-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1a4b3a027152d9d2ccc301954c73f9f |
publicationDate | 2020-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | WO-2019120112-A9 |
titleOfInvention | Use of mimetic antigen compound for treating symptoms related to hbv infections |
abstract | The present invention relates to a method for treating symptoms related to HBV infections, wherein same comprises administering a therapeutically effective amount of a mimetic antigen compound comprising the following two parts to a subject with symptoms related to HBV infections: (1)ε-CH 3(CH 2) 14CO-(NH)-KSSQYIKANSKFIGITE; and (2)AAAFLPSDFFPSVGGGDPRVRGLYFPA. The method of the present invention can induce serum HBeAb seroconversion, i.e. HBeAg/HBeAb serological conversion in HBV-infected patients, reduce the serum HBV DNA level in patients, reduce the serum ALT level and repair damaged liver cells; and therefore, same can become an effective method for treating symptoms related to HBV infections. |
priorityDate | 2017-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 134.